Rebreath Inhalation Solution 3 ml ampoule 6 pcs

480

Quantity: 1

দীর্ঘস্থায়ী অবস্ট্রাকটিভ পালমোনারি ডিজিজ (সিওপিডি) রোগীদের রক্ষণাবেক্ষণের চিকিৎসার জন্য রিব্রেথ নির্দেশিত হয়।

Product Warranty

Payment Methods

payment-logo

About the Product

Full Description

Dosage & Administration:
The recommended dosage is 175 mcg Rebreath (one 175 mcg unit‑dose vial) administered by oral inhalation once daily by nebulizer using a
mouthpiece. Rebreath should be administered by the orally inhaled route via a standard jet nebulizer connected to an air compressor. The safety
and efficacy of Rebreath delivered from non-compressor-based nebulizer systems have not been established. The Rebreath unit-dose vial should
only be removed from the foil pouch and opened immediately before use. The vial and any residual content should be discarded after use.
No dosage adjustment is required for geriatric patients, or patients with renal impairment.

The drug compatibility (physical and chemical), efficacy, and safety of Rebreath when mixed with other drugs in a nebulizer have not been
established.

Side Effects:
Common side effects of Rebreath include:
cough
runny nose
upper respiratory tract infection
headache
back pain

Reviews:


No Review



Cart

0 Items

0
Cart 0 Item
close
close

Your purchase will delivered in 1 shipment

Express delivery
Empty

Your shopping bag is empty. Start shopping now.